Tempest Therapeutics logo

Tempest Therapeutics Share Price Today

(NASDAQ: TPST)

Tempest Therapeutics share price is $0.82 & ₹71.31 as on 6 Mar 2025, 2.30 'hrs' IST

$0.82

0.03

(4.3%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Tempest Therapeutics share price in Dollar and Rupees. Guide to invest in Tempest Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Tempest Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Tempest Therapeutics share price movements

  • Today's Low: $0.78
    Today's High: $0.82

    Day's Volatility :5.68%

  • 52 Weeks Low: $0.70
    52 Weeks High: $6.00

    52 Weeks Volatility :88.36%

Tempest Therapeutics (TPST) Returns

PeriodTempest Therapeutics IncIndex (Russel 2000)
3 Months
-10.9%
0.0%
6 Months
-37.48%
0.0%
1 Year
-78.76%
0.0%
3 Years
-69.94%
-11.6%

Tempest Therapeutics (TPST) Key Statistics

in dollars & INR

Previous Close
$0.7815
Open
$0.7756
Today's High
$0.8223
Today's Low
$0.7756
Market Capitalization
$34.2M
Today's Volume
$144.5K
52 Week High
$6.0
52 Week Low
$0.6986
Revenue TTM
$0.0
EBITDA
$-35.2M
Earnings Per Share (EPS)
$-1.53
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-691.89%

How to invest in Tempest Therapeutics Stock (TPST) from India?

It is very easy for Indian residents to invest directly in Tempest Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Tempest Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Tempest Therapeutics or TPST on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Tempest Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Tempest Therapeutics shares which would translate to 1.061 fractional shares of Tempest Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Tempest Therapeutics, in just a few clicks!

Returns in Tempest Therapeutics (TPST) for Indian investors in Rupees

The Tempest Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tempest Therapeutics investment value today

Current value as on today

₹27,245

Returns

₹72,755

(-72.75%)

Returns from Tempest Therapeutics Stock

₹77,717 (-77.72%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Tempest Therapeutics (TPST)

-45%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Tempest Therapeutics Stock from India on INDmoney has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Tempest Therapeutics

  • Versant Venture Management LLC

    8.04%

  • BlackRock Inc

    1.26%

  • Jane Street Group LLC

    1.13%

  • FMR Inc

    0.99%

  • Geode Capital Management, LLC

    0.81%

  • UBS Group AG

    0.45%

Analyst Recommendation on Tempest Therapeutics

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Tempest Therapeutics(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Tempest Therapeutics Stock (TPST)

What analysts predicted

Upside of 2186.59%

Target:

$18.75

Current:

$0.82

Insights on Tempest Therapeutics Stock (Ticker Symbol: TPST)

  • Price Movement

    In the last 1 year, TPST stock has moved down by -75.3%
  • TPST vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 137.6%
  • TPST vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 120.3%

Tempest Therapeutics Technicals Summary

Sell

Neutral

Buy

Tempest Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Tempest Therapeutics (TPST) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Tempest Therapeutics Inc logo
-14.96%
-37.48%
-78.76%
-69.94%
-94.15%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Tempest Therapeutics Inc logo
NA
NA
NA
-1.31
-6.92
-0.77
NA
0.43
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Tempest Therapeutics Inc logo
Buy
$34.2M
-94.15%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Tempest Therapeutics

Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, which is in a Phase 1 trial to treat cancer; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial for the treatment of solid tumors. It also develops TREX-1, an enzyme that regulates cGAS/STING pathway signaling and immune recognition. The company has agreement with Roche to advance the evaluation of amezalpat (TPST-1120) in combination with atezolizumab (Tecentriq®) and bevacizumab. Tempest Therapeutics, Inc. was incorporated in 2011 and is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.
Organization
Tempest Therapeutics
Employees
17
CEO
Mr. Stephen R. Brady J.D., LLM
Industry
Miscellaneous

Management People of Tempest Therapeutics

NameTitle
Mr. Stephen R. Brady J.D., LLM
CEO, President & Director
Mr. Nicholas Maestas
CFO, Head of Corporate Strategy & Secretary
Dr. Samuel Whiting M.D., Ph.D.
Executive VP, Chief Medical Officer and Head of R&D
Mr. Justin Trojanowski CPA
Corporate Controller, Treasurer & Principal Accounting Officer
Ms. Lindsay Young
Head of Human Resources

Important FAQs about investing in TPST Stock from India :

What is Tempest Therapeutics share price today?

Tempest Therapeutics share price today stands at $0.82, Open: $0.78 ; Previous Close: $0.78 ; High: $0.82 ; Low: $0.78 ; 52 Week High: $6.00 ; 52 Week Low: $0.70.

The stock opens at $0.78, after a previous close of $0.78. The stock reached a daily high of $0.82 and a low of $0.78, with a 52-week high of $6.00 and a 52-week low of $0.70.

Can Indians buy Tempest Therapeutics shares?

Yes, Indians can invest in the Tempest Therapeutics (TPST) from India.

With INDmoney, you can buy Tempest Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Tempest Therapeutics at zero transaction cost.

How can I buy Tempest Therapeutics shares from India?

It is very easy to buy Tempest Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Tempest Therapeutics (TPST) be purchased?

Yes, you can buy fractional shares of Tempest Therapeutics with INDmoney app.

What are the documents required to start investing in Tempest Therapeutics stocks?

To start investing in Tempest Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Tempest Therapeutics Stock (TPST)?

Today’s highest price of Tempest Therapeutics (TPST) is $0.82.

Today’s lowest price of Tempest Therapeutics (TPST) is $0.78.

What is today's market capitalisation of Tempest Therapeutics?

Today's market capitalisation of Tempest Therapeutics TPST is 34.2M

What is the 52 Week High and Low Range of Tempest Therapeutics Stock (TPST)?

  • 52 Week High

    $6.00

  • 52 Week Low

    $0.70

What are the historical returns of Tempest Therapeutics (TPST)?

  • 1 Month Returns

    -14.96%

  • 3 Months Returns

    -37.48%

  • 1 Year Returns

    -78.76%

  • 5 Years Returns

    -94.15%

Who is the Chief Executive Officer (CEO) of Tempest Therapeutics ?

Mr. Stephen R. Brady J.D., LLM is the current Chief Executive Officer (CEO) of Tempest Therapeutics.